ABRAXIS BIO NEW ABII (NASDAQ)

$ 73.71
19:09
Change: +0.41 (+0.56%)
Volume: 21,000

Avg. Volume: 30355
P/E Ratio: 0
EPS (Annual): -1.99
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 40,010
Institutional Shareholders: 14.08%
Last: 73.71
Change: +0.41 (+0.56%)
Prev. Close: 73.30
Open: 71.62
Day's Range: 70.62 - 73.71
52wk Range: 33.00 - 78.95
Market Value: 2,935,590
Beta:
12-month EPS Change: 0.00%
Total Return Last 12 Months: +93.21%
Total Return Last 3 Years: +93.21%
Total Return Last 5 Years: +93.21%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on ABII

Abraxis acquires minority stake in ProMetic

(LOS ANGELES)Abraxis BioScience Inc. said Friday a subsidiary bought more than 15 million common shares of ProMetic Life Sciences Inc., giving it a 4 percent stake in the Canadian biotech compa...READ MORE
Sep 05, 2008 6:11PM
Keywords: ABII, PLI

Abraxis to partner with ProMetic on 4 drugs

(LOS ANGELES)Abraxis BioScience Inc. said Thursday it has reached an agreement with ProMetic Life Sciences Inc. to develop and market four biotech drugs. Abraxis said its potential revenue from...READ MORE
Sep 04, 2008 8:02PM
Keywords: ABII

Earnings roundup: Tribune, Abraxis BioScience

Among the earnings stories for Wednesday, Aug. 13, from AP Financial News: Top stories:READ MORE
Aug 13, 2008 1:39PM
Keywords: ABII, MELI, CRME, SATC

Abraxis shares fall after 2Q loss reported

(LOS ANGELES)Abraxis BioScience Inc. shares fell more than 4 percent Wednesday after the company reported a deeper second-quarter loss driven largely by research and development and litigation ...READ MORE
Aug 13, 2008 1:03PM
Keywords: ABII

Abraxis names CFO, EVP to succeed Lisa Gopala

(LOS ANGELES)Biotechnology company Abraxis BioScience Inc. said Wednesday that it named David O'Toole to succeed Lisa Gopala as chief financial officer and executive vice president.READ MORE
May 28, 2008 9:16AM
Keywords: ABII

Abraxis swings to 1Q profit on Abraxane sales

(LOS ANGELES)Abraxis BioScience Inc. said Thursday it swung to a first-quarter profit , helped by higher sales of the breast cancer treatment Abraxane. The company earned $4.3 million or 11 cen...READ MORE
May 15, 2008 8:04AM
Keywords: ABII

Abraxis BioScience 4Q Loss Widens

(LOS ANGELES)Abraxis BioScience Inc. said Tuesday its fourth-quarter loss widened as a slew of hefty costs offset surging drug sales. The biopharmaceutical company posted a loss of $5.2 million...READ MORE
Apr 01, 2008 8:42AM
Keywords: ABII
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN +28.80 60.41
AMYLIN PHARMA I -56.90 21.11
GILEAD SCIENCES +15.20 47.85
BIOGEN IDEC INC -20.40 48.59
GENENTECH INC +33.90 96.64